Yubo International Biotech Ltd (YBGJ)
1.26
+0.05
(+4.13%)
USD |
OTCM |
Jun 26, 10:34
Yubo International Biotech Cash from Investing (Quarterly): -0.03M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.03M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.0398M |
| June 30, 2022 | 0.0096M |
| March 31, 2022 | -0.0096M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.018M |
| September 30, 2021 | 0.0402M |
| June 30, 2021 | -0.1353M |
| March 31, 2021 | -0.4516M |
| December 31, 2020 | 0.0107M |
| September 30, 2020 | -0.0651M |
| June 30, 2020 | 0.0051M |
| March 31, 2020 | -0.0483M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.4516M
Minimum
Mar 2021
0.0402M
Maximum
Sep 2021
-0.0431M
Average
--
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Meihua International Medical Technologies Co Ltd | -- |
| Hologic Inc | -38.50M |
| Nuwellis Inc | -0.029M |
| Varex Imaging Corp | -1.30M |
| Quanterix Corp | -109.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.1204M |
| Cash from Financing (Quarterly) | 0.098M |
| Free Cash Flow | -0.8567M |
| Free Cash Flow Per Share (Quarterly) | -0.0013 |
| Free Cash Flow to Equity (Quarterly) | -0.1504M |
| Free Cash Flow to Firm (Quarterly) | -0.1503M |
| Free Cash Flow Yield | -0.57% |